Drug Maker Blames ‘Misinformation’ for Zohydro Controversy - National Pain Report
Excerpt:
...“Without justification, inaccurate allegations have been made that Zogenix paid a university to arrange meetings with the FDA to secure approval of Zohydro ER,” wrote Hawley.
“The university in question has declared for the record that, in the meetings it arranged with FDA officials, no representation from Zogenix was present, nor was the company or its products ever discussed. In fact, Zogenix did not even exist as a company at the time of these meetings.”
Some pain patients who want access to Zohydro have told National Pain Report that it is Sen. Manchin who has a conflict of interest.
The senator’s daughter, Heather Bresch, is the CEO of Mylan Inc. (NASDAQ:MYL) a Pittsburgh-based pharmaceutical company that is one of the largest generic drug manufacturers in the world. One of Mylan’s top-selling drugs is a hydrocodone product containing acetaminophen.
Campaign records show that political action committees or individuals associated with Mylan have donated $127,000 to Manchin in the last five years — making Mylan the senator’s second largest corporate contributor...
